179 related articles for article (PubMed ID: 21707682)
1. Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the β-oxidation pathway.
De Preter V; Geboes KP; Bulteel V; Vandermeulen G; Suenaert P; Rutgeerts P; Verbeke K
Aliment Pharmacol Ther; 2011 Sep; 34(5):526-32. PubMed ID: 21707682
[TBL] [Abstract][Full Text] [Related]
2. Pouchitis, similar to active ulcerative colitis, is associated with impaired butyrate oxidation by intestinal mucosa.
De Preter V; Bulteel V; Suenaert P; Geboes KP; De Hertogh G; Luypaerts A; Geboes K; Verbeke K; Rutgeerts P
Inflamm Bowel Dis; 2009 Mar; 15(3):335-40. PubMed ID: 18942762
[TBL] [Abstract][Full Text] [Related]
3. Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway.
De Preter V; Arijs I; Windey K; Vanhove W; Vermeire S; Schuit F; Rutgeerts P; Verbeke K
Inflamm Bowel Dis; 2012 Jun; 18(6):1127-36. PubMed ID: 21987487
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of rectally administering [1-(13)C]-butyrate for breath test in patients with active and quiescent ulcerative colitis.
Kato K; Ishii Y; Mizuno S; Sugitani M; Asai S; Kohno T; Takahashi K; Komuro S; Iwamoto M; Miyamoto S; Takayama T; Arakawa Y
Scand J Gastroenterol; 2007 Feb; 42(2):207-14. PubMed ID: 17327940
[TBL] [Abstract][Full Text] [Related]
5. Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitis.
De Preter V; Arijs I; Windey K; Vanhove W; Vermeire S; Schuit F; Rutgeerts P; Verbeke K
Inflamm Bowel Dis; 2012 Dec; 18(12):2371-80. PubMed ID: 22434643
[TBL] [Abstract][Full Text] [Related]
6. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
[TBL] [Abstract][Full Text] [Related]
7. The colonic epithelium in ulcerative colitis: an energy-deficiency disease?
Roediger WE
Lancet; 1980 Oct; 2(8197):712-5. PubMed ID: 6106826
[TBL] [Abstract][Full Text] [Related]
8. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis.
Chapman MA; Grahn MF; Boyle MA; Hutton M; Rogers J; Williams NS
Gut; 1994 Jan; 35(1):73-6. PubMed ID: 8307454
[TBL] [Abstract][Full Text] [Related]
9. Butyrate increases colonocyte protein synthesis in ulcerative colitis.
Frankel W; Lew J; Su B; Bain A; Klurfeld D; Einhorn E; MacDermott RP; Rombeau J
J Surg Res; 1994 Jul; 57(1):210-4. PubMed ID: 8041140
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC).
Gionchetti P; Campieri M; Belluzzi A; Tampieri M; Bertinelli E; Brignola C; Ferretti M; Boni P; Iannone P; Miglioli M
Agents Actions; 1992; Spec No():C50-2. PubMed ID: 1442335
[TBL] [Abstract][Full Text] [Related]
11. In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis.
Den Hond E; Hiele M; Evenepoel P; Peeters M; Ghoos Y; Rutgeerts P
Gastroenterology; 1998 Sep; 115(3):584-90. PubMed ID: 9721155
[TBL] [Abstract][Full Text] [Related]
12. Ileal and colonic epithelial metabolism in quiescent ulcerative colitis: increased glutamine metabolism in distal colon but no defect in butyrate metabolism.
Finnie IA; Taylor BA; Rhodes JM
Gut; 1993 Nov; 34(11):1552-8. PubMed ID: 8244143
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis.
Vieira EL; Leonel AJ; Sad AP; Beltrão NR; Costa TF; Ferreira TM; Gomes-Santos AC; Faria AM; Peluzio MC; Cara DC; Alvarez-Leite JI
J Nutr Biochem; 2012 May; 23(5):430-6. PubMed ID: 21658926
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
Yantiss RK; Das KM; Farraye FA; Odze RD
Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
[TBL] [Abstract][Full Text] [Related]
15. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
16. Polyamine metabolism in colonic mucosa from patients with ulcerative colitis.
Obayashi M; Matsui-Yuasa I; Matsumoto T; Kitano A; Kobayashi K; Otani S
Am J Gastroenterol; 1992 Jun; 87(6):736-40. PubMed ID: 1590311
[TBL] [Abstract][Full Text] [Related]
17. Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis.
Clausen MR; Mortensen PB
Gut; 1995 Nov; 37(5):684-9. PubMed ID: 8549946
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide and colonic epithelial metabolism: implications for ulcerative colitis.
Jørgensen J; Mortensen PB
Dig Dis Sci; 2001 Aug; 46(8):1722-32. PubMed ID: 11508674
[TBL] [Abstract][Full Text] [Related]
19. Butyrate absorption and lactate secretion in ulcerative colitis.
Hove H; Holtug K; Jeppesen PB; Mortensen PB
Dis Colon Rectum; 1995 May; 38(5):519-25. PubMed ID: 7736884
[TBL] [Abstract][Full Text] [Related]
20. Altered endoplasmic reticulum stress affects translation in inactive colon tissue from patients with ulcerative colitis.
Tréton X; Pédruzzi E; Cazals-Hatem D; Grodet A; Panis Y; Groyer A; Moreau R; Bouhnik Y; Daniel F; Ogier-Denis E
Gastroenterology; 2011 Sep; 141(3):1024-35. PubMed ID: 21699776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
